• DNA Replication, Membrane, and Vacuoles in E. faecalis

  2026-08-16

  Tsuchikado and colleagues show that DNA replication is closely associated with plasma-membrane synthesis and vacuole formation during enlargement of Enterococcus faecalis protoplasts. By varying the timing of novobiocin exposure and removal, the study distinguishes effects on early vacuole formation from effects on continued growth and demonstrates a reversible, replication-dependent control point.

• Fingolimod (FTY720) for Immune-Trafficking Assays

  2026-08-15

  Fingolimod (FTY720) enables a trafficking-first experimental strategy for separating lymphocyte redistribution from T-cell activation, tumor-cell toxicity, and neurobiological signaling. This guide shows how to pair the compound with magnetic bispecific nano-antibody workflows while keeping the combination hypothesis-driven and analytically controlled.

• Maternal Surgery, Calpain, and Offspring Cognition

  2026-08-15

  A 2025 Neuropharmacology study links maternal non-obstetric surgery during pregnancy to offspring cognitive deficits through excessive calpain activity and impaired hippocampal BDNF/TrkB signaling. Its use of both MDL 28170 and a TrkB agonist provides pharmacological evidence that calpain-dependent synaptic and neuronal disruption is functionally relevant, while also defining important limits for translation.

• FPH1 (BRD-6125) Hepatocyte Workflow

  2026-08-14

  FPH1 (BRD-6125) supports expansion and functional evaluation of human hepatocyte models, linking increased cell number with albumin, CYP3A4, and AFP readouts. This workflow shows how to dose, compare, troubleshoot, and interpret the compound without confusing proliferation with maturation.

• BRD4770: G9a Histone Methyltransferase Inhibitor

  2026-08-14

  BRD4770 is a G9a histone methyltransferase inhibitor with a reported enzymatic IC50 of 6.3 μM. Product information links G9a inhibition with reduced intracellular H3K9 methylation, senescence, and suppressed proliferation in PANC-1 cells, while peer-reviewed breast cancer evidence provides pathway context rather than direct BRD4770 validation.

• GW 6471: A Causal Tool for PPARα Studies

  2026-08-13

  GW 6471 is a PPARα antagonist for testing whether receptor activity drives metabolic and toxicological phenotypes. This article translates PFHxS zebrafish evidence into a rigorous, orthogonal assay strategy for cellular metabolism research and lipid homeostasis studies.

• SB 202190: A Translational p38 MAPK Strategy

  2026-08-13

  A thought-leadership framework for using SB202190 (FHPI) to connect p38 biology, patient-derived organoids, pathway-aware assays, and translational decision-making.

• Etoposide (VP-16): From DNA Damage to Translation

  2026-08-12

  A translational framework for using Etoposide (VP-16) to connect topoisomerase II trapping, DNA double-strand breaks, apoptosis, and senescence biomarkers such as cell-surface LAMP1.

• FITC Goat Anti-Rabbit IgG (H+L) Antibody: Gut Assays

  2026-08-12

  Translate rabbit-primary immunofluorescence, flow cytometry, and fluorescent tissue staining into a practical workflow for studying DON-induced intestinal injury. This guide connects FITC signal amplification with the reference study’s lycopene–ERK findings while emphasizing controls, quantitative imaging, and troubleshooting.

• Linarin, c-FOS/ARG2, and Insulin Resistance

  2026-08-11

  This 2025 Phytotherapy Research study combines network pharmacology, molecular docking, palmitate-treated HepG2 cells, and high-fat diet-fed mice to identify linarin as a bioactive Lycii Cortex constituent associated with improved insulin resistance. Its findings connect enhanced glucose uptake and reduced inflammation with the c-FOS/ARG2 signaling axis, while also illustrating how 2-NBDG staining can support mechanistic glucose metabolism research.

• In Vitro Drug Response: Growth Inhibition and Cell Death

  2026-08-10

  Hannah R. Schwartz’s dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer drug response. Its central finding is that most tested drugs influence both proliferation and cell death, but the balance and timing of these effects differ, with important consequences for in vitro study design and interpretation.

• Fasudil (HA-1077) HCl: ROCK Inhibitor Workflows

  2026-08-09

  Build reproducible experiments for Rho/ROCK pathway inhibition, cell migration suppression, and apoptosis analysis with Fasudil (HA-1077) HCl. This guide connects practical ROCK assays with recent Hippo-pathway research while clearly separating validated evidence from exploratory cross-talk studies.

• Alda 1: A Mechanistic Guide to ALDH2 Research

  2026-08-08

  Alda 1 is an ALDH2 activator for dissecting aldehyde detoxification, cardiac stress responses, and genotype-dependent enzyme rescue. This guide connects biochemical assay design with cardioprotection in ischemia, pressure-overload models, and radiation-induced dermatitis mitigation while defining the limits of translational interpretation.

• Lymphodepletion and Neoantigen-Directed T Cell Therapy

  2026-08-07

  Sagie et al. identified a KRAS.G12V-specific T cell receptor and showed that lymphodepleting chemotherapy can improve neoantigen presentation through immunoproteasome activation and increased HLA-I surface expression. The study provides a mechanistic framework for combining chemotherapy with TCR-T cells, tumor-infiltrating lymphocytes, or T cell engagers while highlighting the need to optimize combination regimens rather than treating lymphodepletion as background conditioning.

• Dimetridazole: Mechanistic Synergy & Strategy Against MDR Ba

  2026-08-07

  Explore how Dimetridazole, a 1,2-dimethyl-5-nitroimidazole, enables translational researchers to target multidrug-resistant bacteria through membrane disruption and quorum sensing inhibition. This article blends mechanistic insight, protocol guidance, and a strategic perspective on leveraging Dimetridazole in advanced infection models and combination assays, extending far beyond basic product summaries.

454 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page